|
DERL2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.256800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.725800E-01 |
| Normal-vs-Stage2 |
5.680800E-01 |
| Normal-vs-Stage3 |
4.233800E-02 |
| Normal-vs-Stage4 |
9.862500E-03 |
| Stage1-vs-Stage2 |
2.094800E-01 |
| Stage1-vs-Stage3 |
1.377320E-03 |
| Stage1-vs-Stage4 |
1.414500E-04 |
| Stage2-vs-Stage3 |
3.744200E-01 |
| Stage2-vs-Stage4 |
1.886640E-01 |
| Stage3-vs-Stage4 |
6.361200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.784200E-01 |
| Normal-vs-AfricanAmerican |
7.728200E-02 |
| Normal-vs-Asian |
4.661600E-01 |
| Caucasian-vs-AfricanAmerican |
3.962700E-03 |
| Caucasian-vs-Asian |
8.163400E-01 |
| AfricanAmerican-vs-Asian |
1.474190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.109000E-01 |
| Normal-vs-Female |
3.188400E-02 |
| Male-vs-Female |
8.195400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.210800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.332800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.299000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.211800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.378400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.489400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.452400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.294200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.623600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.662800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.916160E-01 |
| Normal-vs-Grade 2 |
7.898000E-01 |
| Normal-vs-Grade 3 |
4.560400E-01 |
| Normal-vs-Grade 4 |
5.396700E-03 |
| Grade 1-vs-Grade 2 |
3.222400E-01 |
| Grade 1-vs-Grade 3 |
5.815900E-02 |
| Grade 1-vs-Grade 4 |
1.175460E-03 |
| Grade 2-vs-Grade 3 |
2.362000E-01 |
| Grade 2-vs-Grade 4 |
1.956700E-03 |
| Grade 3-vs-Grade 4 |
1.611690E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.125400E-01 |
| Normal-vs-ccB subtype |
4.530000E-01 |
| ccA subtype-vs-ccB subtype |
7.084600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.047000E-01 |
| Normal-vs-N1 |
4.96219999979175E-07 |
| N0-vs-N1 |
1.499420E-03 |
|
|
